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We report here the draft genome sequence of uropathogenic Escherichia coli sequence type 648 (ST648) possessing blaNDM-5
from a 55-year-old female in Australia with a history of travel to India. The plasmid-mediated blaNDM-5 was in a genetic context
nearly identical to that of the GenBank entry of an IncX3 blaNDM-5 plasmid previously reported from India (Klebsiella pneu-
moniaeMGR-K194).
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The Indian subcontinent has been reported as a geographicalreservoir for the acquisition of NDM-producing Enterobac-
teriaceae (1). A 55-year-old female with chronic diarrhea had
carbapenem-resistant Escherichia coli isolated from a urine sam-
ple in January 2014. She traveled to India in late 2013 and devel-
oped diarrhea but was not admitted to a medical facility. Upon her
return to Australia, ongoing diarrhea prompted multiple hospital
admissions. She was diagnosed with Crohn’s disease. During ad-
mission, a midstream urine sample was collected, from which the
carbapenem-resistant E. coli CR694 was identified.
Whole-genomic DNA of E. coli CR694 was prepared using the
Nextera XT DNA sample preparation kit (Illumina, USA) and
sequenced using the Illumina HiSeq 2000 (Illumina) at the Aus-
tralian Genome Research Facility. De novo assembly was per-
formed using CLC Genomics Workbench version 7.5 (CLC bio,
Denmark). The draft genome consists of 5,523,407 bp. The con-
tigs were initially annotated using RAST (http://rast.nmpdr.org/).
A BLAST analysis and manual annotation utilized previously re-
annotated reference sequences and IS Finder (https://www-is
.biotoul.fr/). The MLST, ResFinder, and PlasmidFinder (http:
//www.genomicepidemiology.org/) databases were used to char-
acterize sequence typing (ST), antibiotic resistance mechanisms,
and the plasmid Inc types, respectively, of E. coli CR694. ST648,
plasmid Inc types of IncFII, IncFIB, IncX3, IncI1, and IncX4, and
the genes blaNDM-5, blaCMY-42, aac-6-Ib-cr, aadA5, erm(B),
mph(A), sul1, tet(B), and dfrA17 were identified.
Additionally, the annotation through RAST identified the type
1 fimbriae genes fimABCDEFGHI, virulence determinants rele-
vant for urinary tract adhesion (2). Further, five other types of
fimbriae were identified as a membrane transport type VII protein
secretion system, namely the (i) htrE fimbriae cluster, (ii) stf fim-
briae cluster, (iii) alpha-fimbriae, (iv) colonization factor antigen
I fimbriae (CFA/I fimbriae), and (v) sfm fimbrial cluster. A cluster
responsible for curli production or type VIII secretion was iden-
tified. Siderophore enterobactin, aerobactin, and other hemin
transport systems for iron acquisition were identified. In addition,
type IV pilus and an IncF conjugal transfer system were identified.
A gene for serum survival (iss) was also identified. The identified
virulence determinants may have contributed to the infection and
or colonization of CR694 in the urinary tract (2).
The contig pCR694-EC-NDM-5 carried the blaNDM-5 genetic
context. blaNDM has been reported to reside within a 10,099-bp
transposon known as Tn125 (3). blaNDM-5 on pCR694-EC-
NDM-5 was found to be located within a truncated 3,167 bp
Tn125 structure, flanked by an IS5 upstream and an IS26 down-
stream. pCR694-EC-NDM-5 was identical to an NDM-5 IncX3
plasmid, pNDM-MGR194 (as a direct submission, with GenBank
accession no. KF220657) (4). Both blaNDM-5 genetic contexts did
not possess the Tn125-associated genes groES, groEL, and ISCR27.
Both pCR694-EC-NDM-5 and pNDM-MGR194 are also highly
similar to NDM-1 IncX plasmid pKPN5047 (GenBank accession
no. NC_020811), containing a longer Tn125 structure in which
groES, groEL, and ISCR27 are present.
The blaNDM-5 genetic context of pCR694-EC-NDM-5 has not
been reported within E. coli or within Australia. NDM-5-
producing Enterobacteriaceae have been reported in Japan, Alge-
ria, the United Kingdom, and India, of which an E. coli ST648
harbored blaNDM-5 in both the aforementioned United Kingdom
and Japan reports (5–8). This case of an NDM-5-producing typi-
cal uropathogenic E. coli isolate highlights the further interconti-
nental acquisition of carbapenemase-producing Enterobacteri-
aceae through travel to geographical reservoirs.
This work was approved by the Royal Brisbane and Women’s
Human Research Ethics Committee (HREC/13/QRBW/391: Epi-
demiology, clinical significance, treatment and outcome of infec-
tions by carbapenem-resistant Enterobacteriaceae and Acinetobac-
ter spp. in Queensland).
Nucleotide sequence accession numbers. This project is registered
as BioProject PRJNA268254 and BioSample SAMN03217331. The
blaNDM-5 genetic context pCR694-EC-NDM-5 was submitted to
the GenBank database and assigned the accession no. KP178355.
The draft genome sequence of NDM-5-producing E. coli ST648 has
been deposited in GenBank under accession no. JTGI00000000.
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